Introducing mgTag and cTag

How do you study the 90% of proteins that lack small-molecule binding partners? By tagging the protein!

The problem is that most tags are too bulky, like trying to study a butterfly ๐Ÿฆ‹ with a bowling ball attached.

To address this limitation, researchers at the Broad Institute developed two novel protein tags which were published in Angewandte Chemie:

“๐˜œ๐˜ญ๐˜ต๐˜ณ๐˜ข๐˜ด๐˜ฎ๐˜ข๐˜ญ๐˜ญ ๐˜Š๐˜ฉ๐˜ฆ๐˜ฎ๐˜ฐ๐˜จ๐˜ฆ๐˜ฏ๐˜ฆ๐˜ต๐˜ช๐˜ค ๐˜›๐˜ข๐˜จ๐˜ด ๐˜ธ๐˜ช๐˜ต๐˜ฉ ๐˜Ž๐˜ณ๐˜ฐ๐˜ถ๐˜ฑ-๐˜›๐˜ณ๐˜ข๐˜ฏ๐˜ด๐˜ง๐˜ฆ๐˜ณ ๐˜“๐˜ช๐˜จ๐˜ข๐˜ฏ๐˜ฅ๐˜ด”

My highlights
Size:
๐Ÿ”ธ mgTag: 36 amino acids
๐Ÿ”ธ cTag: 50 amino acids

โœ”๏ธ Both tags use “transferase-type reactivity” (exploiting the same mechanism cells use naturally) โžก๏ธ allowing attachment of any moiety-of-interest to the tag โ—
โœ”๏ธ The mgTag operates through a molecular glue system requiring cereblon (CRBN)
โœ”๏ธ cTag uses an engineered C1 domain from protein kinase C
โœ”๏ธ The smallest covalent chemogenetic tags developed to date
โœ”๏ธ Both tags are of human origin: suitable for applications requiring reduced immunogenicity

This technology can find applications in basic science, proximity inducing modalities, biotechnology, and medicine, including potential use in CRISPR-based knock-in technologies and synthetic biology applications.

Share your opinion
What applications do you see for these novel protein tags โ“
Share your thoughts in comments below.

Leave your comment under my LinkedIn post here.

Full manuscript: https://doi.org/10.1002/anie.202506997Digital Object Identifier (DOI)